Mirabella Financial Services LLP Protalix Bio Therapeutics, Inc. Transaction History
Mirabella Financial Services LLP
- $1.15 Billion
- Q2 2024
A detailed history of Mirabella Financial Services LLP transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Mirabella Financial Services LLP holds 30,000 shares of PLX stock, worth $34,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$34,800% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PLX
# of Institutions
63Shares Held
5.83MCall Options Held
103KPut Options Held
4.6K-
Israel Englander Millennium Management LLC | New York, Ny811KShares$940,9450.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny805KShares$933,3350.0% of portfolio
-
Goldman Sachs Group Inc New York, NY462KShares$535,8710.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$504,8470.03% of portfolio
-
Northern Trust Corp Chicago, IL423KShares$490,9270.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $57.7M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...